Showing results (171-180 of 461) with videos related to
Sort By:
Pageof 47
Cancers|February 11, 2023
Metabolic Reprogramming in Colon Cancer Cells Persistently Infected with Newcastle Disease VirusTong Yu, Archana Chandrabhan Jadhav, Jiabao Xu, et al.Cancer Research|October 6, 2005
Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell functionNilay S Patel, Ji-Liang Li, Daniele Generali, et al.Oncology Research|June 21, 2006
The role of cell-free DNA size distribution in the management of prostate cancerJane L Boddy, Shira Gal, Peter R Malone, et al.Plos Biology|January 5, 2011
HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancerMerel Gijsen, Peter King, Tim Perera, et al.The Journal of Pathology|June 29, 2004
The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in human tissues and tumoursHelen Turley, Charles C Wykoff, Sandra Troup, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 1, 2005
Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1alpha expressionAlexandra Giatromanolaki, Michael I Koukourakis, Efthimios Sivridis, et al.Oncotarget|August 12, 2010
Overexpression of POLQ confers a poor prognosis in early breast cancer patientsGeoff S Higgins, Adrian L Harris, Remko Prevo, et al.Medical Oncology (Northwood, London, England)|July 26, 2019
Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysisAlexandra Giatromanolaki, Ioannis M Koukourakis, Konstantina Balaska, et al.Cancer Chemotherapy and Pharmacology|October 24, 2003
Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1 alphaMichael I Koukourakis, Alexandra Giatromanolaki, Wen Chong, et al.Cancer Research|May 7, 2009
The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with BortezomibManuela Milani, Tomasz Rzymski, Howard R Mellor, et al.Pageof 47